Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58


Personalized medicine in Europe: not yet personal enough?

Di Paolo A, Sarkozy F, Ryll B, Siebert U.

BMC Health Serv Res. 2017 Apr 19;17(1):289. doi: 10.1186/s12913-017-2205-4. Review.


Prostate cancer treated with brachytherapy; an exploratory study of dose-dependent biomarkers and quality of life.

Osman SO, Horn S, Brady D, McMahon SJ, Yoosuf AB, Mitchell D, Crowther K, Lyons CA, Hounsell AR, Prise KM, McGarry CK, Jain S, O'Sullivan JM.

Radiat Oncol. 2017 Mar 14;12(1):53. doi: 10.1186/s13014-017-0792-1.


Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey.

Lehto US, Tenhola H, Taari K, Aromaa A.

Br J Cancer. 2017 Mar 28;116(7):864-873. doi: 10.1038/bjc.2017.30. Epub 2017 Feb 21.


Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer.

Hatiboglu G, Popeneciu IV, Deppert M, Nyarangi-Dix J, Hadaschik B, Hohenfellner M, Teber D, Pahernik S.

BMC Urol. 2017 Jan 11;17(1):5. doi: 10.1186/s12894-017-0198-2.


Bladder neck preservation improves time to continence after radical prostatectomy: a systematic review and meta-analysis.

Ma X, Tang K, Yang C, Wu G, Xu N, Wang M, Zeng X, Hu Z, Song R, Yuh B, Wang Z, Ye Z.

Oncotarget. 2016 Oct 11;7(41):67463-67475. doi: 10.18632/oncotarget.11997.


New Paradigms for Patient-Centered Outcomes Research in Electronic Medical Records: An Example of Detecting Urinary Incontinence Following Prostatectomy.

Hernandez-Boussard T, Tamang S, Blayney D, Brooks J, Shah N.

EGEMS (Wash DC). 2016 May 12;4(3):1231. doi: 10.13063/2327-9214.1231. eCollection 2016.


Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study.

Fridriksson JÖ, Folkvaljon Y, Nilsson P, Robinson D, Franck-Lissbrant I, Ehdaie B, Eastham JA, Widmark A, Karlsson CT, Stattin P.

Scand J Urol. 2016 Oct;50(5):338-45. doi: 10.1080/21681805.2016.1194460. Epub 2016 Jun 22.


Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.

Taylor KL, Hoffman RM, Davis KM, Luta G, Leimpeter A, Lobo T, Kelly SP, Shan J, Aaronson D, Tomko CA, Starosta AJ, Hagerman CJ, Van Den Eeden SK.

Cancer Epidemiol Biomarkers Prev. 2016 Aug;25(8):1240-50. doi: 10.1158/1055-9965.EPI-15-1079. Epub 2016 Jun 2.


Investigating Respondents and Nonrespondents of a Postal Breast Cancer Questionnaire Survey Regarding Differences in Age, Medical Conditions, and Therapy.

Frobeen AL, Kowalski C, Weiß V, Pfaff H.

Breast Care (Basel). 2016 Apr;11(2):139-43. doi: 10.1159/000446015. Epub 2016 Apr 27.


Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience.

Mercado C, Kress MA, Cyr RA, Chen LN, Yung TM, Bullock EG, Lei S, Collins BT, Satinsky AN, Harter KW, Suy S, Dritschilo A, Lynch JH, Collins SP.

Front Oncol. 2016 May 6;6:114. doi: 10.3389/fonc.2016.00114. eCollection 2016.


Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer.

Zelefsky MJ, Poon BY, Eastham J, Vickers A, Pei X, Scardino PT.

Radiother Oncol. 2016 Jan;118(1):85-91. doi: 10.1016/j.radonc.2015.11.035. Epub 2016 Jan 9.


High-Intensity Focused Ultrasound: Current Status for Image-Guided Therapy.

Copelan A, Hartman J, Chehab M, Venkatesan AM.

Semin Intervent Radiol. 2015 Dec;32(4):398-415. doi: 10.1055/s-0035-1564793. Review.


Physical activity, sedentary behavior, and health-related quality of life in prostate cancer survivors in the health professionals follow-up study.

Phillips SM, Stampfer MJ, Chan JM, Giovannucci EL, Kenfield SA.

J Cancer Surviv. 2015 Sep;9(3):500-11. doi: 10.1007/s11764-015-0426-2. Epub 2015 Apr 16.


Achieving optimal delivery of follow-up care for prostate cancer survivors: improving patient outcomes.

Hudson SV, O'Malley DM, Miller SM.

Patient Relat Outcome Meas. 2015 Mar 19;6:75-90. doi: 10.2147/PROM.S49588. eCollection 2015. Review.


Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form.

Skolarus TA, Dunn RL, Sanda MG, Chang P, Greenfield TK, Litwin MS, Wei JT; PROSTQA Consortium.

Urology. 2015 Jan;85(1):101-5. doi: 10.1016/j.urology.2014.08.044.


Oncological and functional outcomes of 722 robot-assisted radical prostatectomy (RARP) cases: The largest Canadian 5-year experience.

Tholomier C, Bienz M, Hueber PA, Trinh QD, Hakim AE, Alhathal N, Lebeau T, Benayoun S, Valdivieso R, Liberman D, Saad F, Lattouf JB, Widmer H, Begin L, Latour M, Zorn KC.

Can Urol Assoc J. 2014 May;8(5-6):195-201. doi: 10.5489/cuaj.2016. Erratum in: Can Urol Assoc J. 2015 Sep-Oct;9(9-10):E760.


Characteristics and experiences of patients with localized prostate cancer who left an active surveillance program.

Berger ZD, Yeh JC, Carter HB, Pollack CE.

Patient. 2014;7(4):427-36. doi: 10.1007/s40271-014-0066-z.


Failure to address potential bias in non-randomised controlled clinical trials may cause lack of evidence on patient-reported outcomes: a method study.

Peinemann F, Labeit AM, Thielscher C, Pinkawa M.

BMJ Open. 2014 Jun 4;4(6):e004720. doi: 10.1136/bmjopen-2013-004720.


Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments.

Schmidt S, Garin O, Pardo Y, Valderas JM, Alonso J, Rebollo P, Rajmil L, Garcia-Forero C, Ferrer M; EMPRO Group.

Qual Life Res. 2014 Oct;23(8):2169-81. doi: 10.1007/s11136-014-0678-8. Epub 2014 Apr 19.


Quality of Life and Sexual Health in the Aging of PCa Survivors.

Gacci M, Baldi E, Tamburrino L, Detti B, Livi L, De Nunzio C, Tubaro A, Gravas S, Carini M, Serni S.

Int J Endocrinol. 2014;2014:470592. doi: 10.1155/2014/470592. Epub 2014 Mar 17. Review. Erratum in: Int J Endocrinol. 2015;2015:675101.

Supplemental Content

Support Center